SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     



J Nucl Med. 2008; 49 (Supplement 1):305P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Cistaro, A.
Right arrow Articles by Ficola, U.
PubMed
Right arrow Articles by Cistaro, A.
Right arrow Articles by Ficola, U.

Radiopharmaceutical Chemistry: Radiopharmacy

Radiopharmacy Posters

THE "RP 500 Sciara": A revolutionary system to inject PET traces

Angelina Cistaro1, Rino D'Agata2, Alfredo Speranzi2 and Umberto Ficola3

1 Nuclear Medicine, IRMET S.p.A. PET Center, Torino, Italy; 2 Unit of Nuclear Medicine, University Dept Careggi Hospital, Florence, Italy; 3 Nuclear Medicine and Metabolic Radiotherapy Dept, "La Maddalena" Oncologic Hospital, Palerm, Italy

1297

Objectives: PET development in clinical research has contributed to a better knowledge in oncologic field. Therefore, in the last years, the number of PET diagnosis has grown massively thanks to a larger production of PET traces, particularly 18F-FDG. This has pushed Nuclear Medicine operators towards an increased exposure due to manipolation of PET traces. In the attempt to minimize the exposure doses, the Maspres company has develop a new system able to inject drugs to patients in an automatic manner.

Methods: The "RP 500 Sciara" is an automatic system that allows to inject PET traces without any operator exposure. The system is controlled through a dedicated hardware and software. It works within an inoxidizable steel box, lead shielded, to guarantee the maximum safety radioprotection. The whole process is managed by a dedicated software that drive step by step the operator in the correct injection procedure. The activity submitted to patient is stablished by the operator and it is determined by subtraction from the starting vial, situated in a dose calibrator containing PET traces. The operator has the control over the entire process, since he could stop RP 500 Sciara system whenever he want, and start it again.

Results: We carried out 60 tests. The activity gived up deviation(delta) from activity injected ranged from +0,08 to -0,03.

Conclusions: RP 500 Sciara has been created to performe important aims: 1. To assure the best precision in dose administration 2. To drastically reduce the radioactive exposure of the Nuclear Medicine operator 3. To inject PET tracers in a quickly and easy manner

Research Support: Maspres





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Cistaro, A.
Right arrow Articles by Ficola, U.
PubMed
Right arrow Articles by Cistaro, A.
Right arrow Articles by Ficola, U.